A study identified possible prognostic factors and survival patterns based on histology type in endometrial cancer patients. A study analyzed the correlation between cancer-related cognitive impairment and neurotransmission pathways. Dr. Andrew Hertler explains why health disparities exist for Black women with ovarian cancer. Sexual counseling training in gynecological cancers is effective at generating increased awareness among midwifery students. The FDA approved dostarlimab-gxly with carboplatin and paclitaxel for endometrial cancer. The FDA approved pembrolizumab with chemotherapy for adult patients with primary advanced, recurrent endometrial carcinoma. Pembrolizumab use is increasing among patients with recurrent cervical cancer. An objective manual screening process may enhance diversity in gynecologic cancer clinical trial enrollment. Camrelizumab plus apatinib demonstrates robust and sustained efficacy in treating patients with advanced cervical cancer. The FDA granted approval to tisotumab vedotin-tftv for the treatment of recurrent or metastatic cervical cancer. The addition of dostarlimab to platinum chemotherapy is cost effective and significantly improves QOL. A blood-based machine learning assay may be able to differentiate patients with ovarian cancer from healthy patients. According to a retrospective study, a high preoperative CONUT score indicates poor prognosis in cervical cancer. According to a report, published in the Journal of Contemporary Brachytherapy, patients with gynecologic malignancies ... The U.S. Food and Drug Administration (FDA) approved Lynparza® (olaparib) in combination with Avastin® (bevacizumab) ... Fragmentation of care is associated with an increased risk for adverse outcomes, but data are limited on this topic in ... Among female cancer patients, obesity and low levels of physical activity may be associated with increased inflammation ... 2019 Society of Gynecologic Oncology Annual Meeting, there were no significant differences in outcomes based on age ... According to the Centers for Disease Control and Prevention (CDC), uterine cancer incidence and mortality is on the ... Patients with uterine serous carcinoma are at an increased risk of developing venous thromboembolism (VTE) not just ...